p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation

Feng Bai, Ho Lam Chan, Matthew D. Smith, Hiroaki Kiyokawa, Xin-Hai Pei

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Pituitary tumors develop in about one-quarter of the population, and most arise from the anterior lobe (AL). The pituitary gland is particularly sensitive to genetic alteration of genes involved in the cyclin-dependent kinase (CDK) inhibitor (CKI)-CDK-retinoblastoma protein (Rb) pathway. Mice heterozygous for the Rb mutation develop pituitary tumors, with about 20% arising from the AL. Perplexingly, none of the CKI-deficient mice reported thus far develop pituitary AL tumors. In this study, we show that deletion of p19Ink4d (p19), a CKI gene, in mice results in spontaneous development of tumors in multiple organs and tissues. Specifically, more than one-half of the mutant mice developed pituitary hyperplasia or tumors predominantly in the AL. Tumor development is associated with increased cell proliferation and enhanced activity of Cdk4 and Cdk6 and phosphorylation of Rb protein. Though Cdk4 is indispensable for postnatal pituitary cell proliferation, it is not required for the hyperproliferative pituitary phenotype caused by p19 loss. Loss of p19 phosphorylates Rb in Cdk4-/-pituitary AL cells and mouse embryonic fibroblasts (MEFs) and rescues their proliferation defects, at least partially, through the activation of Cdk6. These results provide the first genetic evidence that p19 is a tumor suppressor and the major CKI gene that controls pituitary AL cell proliferation.

Original languageEnglish
Pages (from-to)2121-2134
Number of pages14
JournalMolecular and Cellular Biology
Volume34
Issue number12
DOIs
StatePublished - Jan 1 2014

Fingerprint

Anterior Pituitary Gland
Cell Proliferation
Retinoblastoma Protein
Cyclin-Dependent Kinases
Pituitary Neoplasms
Neoplasms
Genes
Pituitary Gland
Hyperplasia
Fibroblasts
Phosphorylation
Phenotype
Mutation
Population

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation. / Bai, Feng; Chan, Ho Lam; Smith, Matthew D.; Kiyokawa, Hiroaki; Pei, Xin-Hai.

In: Molecular and Cellular Biology, Vol. 34, No. 12, 01.01.2014, p. 2121-2134.

Research output: Contribution to journalArticle

Bai, Feng ; Chan, Ho Lam ; Smith, Matthew D. ; Kiyokawa, Hiroaki ; Pei, Xin-Hai. / p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation. In: Molecular and Cellular Biology. 2014 ; Vol. 34, No. 12. pp. 2121-2134.
@article{68e97ede10ea45239b94c0c1d9713645,
title = "p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation",
abstract = "Pituitary tumors develop in about one-quarter of the population, and most arise from the anterior lobe (AL). The pituitary gland is particularly sensitive to genetic alteration of genes involved in the cyclin-dependent kinase (CDK) inhibitor (CKI)-CDK-retinoblastoma protein (Rb) pathway. Mice heterozygous for the Rb mutation develop pituitary tumors, with about 20{\%} arising from the AL. Perplexingly, none of the CKI-deficient mice reported thus far develop pituitary AL tumors. In this study, we show that deletion of p19Ink4d (p19), a CKI gene, in mice results in spontaneous development of tumors in multiple organs and tissues. Specifically, more than one-half of the mutant mice developed pituitary hyperplasia or tumors predominantly in the AL. Tumor development is associated with increased cell proliferation and enhanced activity of Cdk4 and Cdk6 and phosphorylation of Rb protein. Though Cdk4 is indispensable for postnatal pituitary cell proliferation, it is not required for the hyperproliferative pituitary phenotype caused by p19 loss. Loss of p19 phosphorylates Rb in Cdk4-/-pituitary AL cells and mouse embryonic fibroblasts (MEFs) and rescues their proliferation defects, at least partially, through the activation of Cdk6. These results provide the first genetic evidence that p19 is a tumor suppressor and the major CKI gene that controls pituitary AL cell proliferation.",
author = "Feng Bai and Chan, {Ho Lam} and Smith, {Matthew D.} and Hiroaki Kiyokawa and Xin-Hai Pei",
year = "2014",
month = "1",
day = "1",
doi = "10.1128/MCB.01363-13",
language = "English",
volume = "34",
pages = "2121--2134",
journal = "Molecular and Cellular Biology",
issn = "0270-7306",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - p19Ink4d is a tumor suppressor and controls pituitary anterior lobe cell proliferation

AU - Bai, Feng

AU - Chan, Ho Lam

AU - Smith, Matthew D.

AU - Kiyokawa, Hiroaki

AU - Pei, Xin-Hai

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Pituitary tumors develop in about one-quarter of the population, and most arise from the anterior lobe (AL). The pituitary gland is particularly sensitive to genetic alteration of genes involved in the cyclin-dependent kinase (CDK) inhibitor (CKI)-CDK-retinoblastoma protein (Rb) pathway. Mice heterozygous for the Rb mutation develop pituitary tumors, with about 20% arising from the AL. Perplexingly, none of the CKI-deficient mice reported thus far develop pituitary AL tumors. In this study, we show that deletion of p19Ink4d (p19), a CKI gene, in mice results in spontaneous development of tumors in multiple organs and tissues. Specifically, more than one-half of the mutant mice developed pituitary hyperplasia or tumors predominantly in the AL. Tumor development is associated with increased cell proliferation and enhanced activity of Cdk4 and Cdk6 and phosphorylation of Rb protein. Though Cdk4 is indispensable for postnatal pituitary cell proliferation, it is not required for the hyperproliferative pituitary phenotype caused by p19 loss. Loss of p19 phosphorylates Rb in Cdk4-/-pituitary AL cells and mouse embryonic fibroblasts (MEFs) and rescues their proliferation defects, at least partially, through the activation of Cdk6. These results provide the first genetic evidence that p19 is a tumor suppressor and the major CKI gene that controls pituitary AL cell proliferation.

AB - Pituitary tumors develop in about one-quarter of the population, and most arise from the anterior lobe (AL). The pituitary gland is particularly sensitive to genetic alteration of genes involved in the cyclin-dependent kinase (CDK) inhibitor (CKI)-CDK-retinoblastoma protein (Rb) pathway. Mice heterozygous for the Rb mutation develop pituitary tumors, with about 20% arising from the AL. Perplexingly, none of the CKI-deficient mice reported thus far develop pituitary AL tumors. In this study, we show that deletion of p19Ink4d (p19), a CKI gene, in mice results in spontaneous development of tumors in multiple organs and tissues. Specifically, more than one-half of the mutant mice developed pituitary hyperplasia or tumors predominantly in the AL. Tumor development is associated with increased cell proliferation and enhanced activity of Cdk4 and Cdk6 and phosphorylation of Rb protein. Though Cdk4 is indispensable for postnatal pituitary cell proliferation, it is not required for the hyperproliferative pituitary phenotype caused by p19 loss. Loss of p19 phosphorylates Rb in Cdk4-/-pituitary AL cells and mouse embryonic fibroblasts (MEFs) and rescues their proliferation defects, at least partially, through the activation of Cdk6. These results provide the first genetic evidence that p19 is a tumor suppressor and the major CKI gene that controls pituitary AL cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=84901361194&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901361194&partnerID=8YFLogxK

U2 - 10.1128/MCB.01363-13

DO - 10.1128/MCB.01363-13

M3 - Article

C2 - 24687853

AN - SCOPUS:84901361194

VL - 34

SP - 2121

EP - 2134

JO - Molecular and Cellular Biology

JF - Molecular and Cellular Biology

SN - 0270-7306

IS - 12

ER -